2020 Quality Measure Development CHASE Board August 27, 2019 - - PowerPoint PPT Presentation

2020 quality measure
SMART_READER_LITE
LIVE PREVIEW

2020 Quality Measure Development CHASE Board August 27, 2019 - - PowerPoint PPT Presentation

HQIP 2019 Scoring and 2020 Quality Measure Development CHASE Board August 27, 2019 Nancy Dolson Department of Health Care Policy & Financing Agenda 1. 2019 CO HQIP Scoring 2. 2020 CO HQIP Proposed Quality Measures Review of 2019


slide-1
SLIDE 1

HQIP 2019 Scoring and 2020 Quality Measure Development

CHASE Board August 27, 2019

Nancy Dolson Department of Health Care Policy & Financing

slide-2
SLIDE 2

Agenda

  • 1. 2019 CO HQIP Scoring
  • 2. 2020 CO HQIP Proposed Quality Measures
  • Review of 2019 Measures
  • Proposed Changes for 2020

2

slide-3
SLIDE 3

2019 Scoring: Cesarean Section

3

The HQIP Subcommittee has voted to apply the 2018 bounds to this year’s distribution. Healthy People 2020’s benchmark of 23.9% was used as the cutoff for scoring eligibility.

C-section Lower Bound Upper Bound Points

  • No. of facilities

1st Tercile (lowest) 0.0% 17.2% 4 17 2nd Tercile 17.3% 20.8% 2 10 3rd Tercile 20.9% 23.8% 1 7 ≥ 23.9% (highest) 23.9% 100.0% 12 Ineligible* 36 Total 82

*Ineligible facilities (those that do not provide obstetric services or do not meet the minimum number of qualified deliveries)

will have their scores normalized for this measure.

slide-4
SLIDE 4

2019 Scoring: Falls with Injury

4

Falls with Injury (rate per 1000 inpatient days) Lower Bound Upper Bound Points

  • No. of facilities

1st Quartile (lowest) 0.00 0.08 5 41 2nd Quartile 0.09 0.21 3 13 3rd Quartile 0.22 0.64 1 14 4th Quartile (highest) 0.65 38.96 14 Total 82

slide-5
SLIDE 5

2019 Scoring: Advance Care Planning

5

The HQIP Subcommittee has voted to apply the 2018 bounds to this year’s distribution. The 2018 method excluded those with 0% ACP from calculation and awarded maximum points for those greater than or equal to 99.5%.

Advance Care Planning Lower Bound Upper Bound Points

  • No. of facilities

4th Quartile (highest) 99.5% 100.0% 3 26 3rd Quartile 86.4% 99.4% 2 32 2nd Quartile 75.0% 86.3% 1 3 1st Quartile (lowest) 0% 74.9% 21 Total 82

slide-6
SLIDE 6

2019 Scoring: HCAHPS, Composite 5

6

The Communication about Medicines measure reflects patients’ feedback on how often hospital staff explained the purpose of any new medicine and what side effects that medicine might have.

‘Always’ Percentage Lower Bound Upper Bound Points

  • No. of facilities

4th Quartile (highest) 70% 86% 4 15 3rd Quartile 67% 69% 2 11 2nd Quartile 65% 66% 1 16 1st Quartile (lowest) 0% 64% 20 Not Available* 20 Total 82

*Not Available group includes those with suppressed scores due to insufficient responses and rehabilitation facilities that are

not required to implement the HCAHPS survey. Scores will be normalized.

slide-7
SLIDE 7

2019 Scoring: HCAHPS, Composite 6

7

The Discharge Information measure summarizes how well the hospital staff communicated with patients about the help they would need at home after leaving the hospital. The measure also summarizes how

  • ften patients reported that they were given written information about

symptoms or health problems to watch for during their recovery.

‘Yes’ Percentage Lower Bound Upper Bound Points

  • No. of facilities

4th Quartile (highest) 91% 95% 4 14 3rd Quartile 90% 90% 2 12 2nd Quartile 89% 89% 1 9 1st Quartile (lowest) 0% 88% 27 Not Available* 20 Total 82

*Not Available group includes those with suppressed scores due to insufficient responses and rehabilitation facilities that are

not required to implement the HCAHPS survey. Scores will be normalized.

slide-8
SLIDE 8

2019 Scoring: HCAHPS, Composite 7

8

The Care Transition measure evaluates the degree to which patients understood their care when they left the hospital.

‘Strongly Agree’ Percentage Lower Bound Upper Bound Points

  • No. of facilities

4th Quartile (highest) 59% 71% 4 14 3rd Quartile 56% 58% 2 14 2nd Quartile 53% 55% 1 17 1st Quartile (lowest) 0% 52% 17 Not Available* 20 Total 82

*Not Available group includes those with suppressed scores due to insufficient responses and rehabilitation facilities that are

not required to implement the HCAHPS survey. Scores will be normalized.

slide-9
SLIDE 9

2020 Quality Measures

Review of 2019 Measures Proposed Changes for 2020

9

slide-10
SLIDE 10

2019 Quality Measures

Measure Group Measure Status Data Goal Perinatal and Maternal Care Breast Feeding Existing Hospital Reported Process C-Section Existing Hospital Reported Outcome Pregnancy related depression New Hospital Reported Process Maternal Emergencies New Hospital Reported Process Family Planning New HCPF/Hospital Report Process Patient Safety Clostridium difficile (C-Diff) Existing HCPF/Hospital Report Outcome Adverse Event Existing Hospital Reported Process Falls w/Injury Existing Hospital Reported Outcome Culture of Safety Survey Existing Hospital Reported Process Patient Experience HCAHPS New HCPF Outcome Advanced Care Plan Existing Hospital Reported Process Behavioral Health Follow-Up after Hospitalization for Mental Illness New HCPF Outcome ED Utilization MH New HCPF Outcome ED Utilization SUD New HCPF Outcome Substance Use SUB Composite New Hospital Reported Outcome ALTO and Post-Surg New Hospital Reported Process Addressing Cost of Care Hospital Index New HCPF Outcome

10

slide-11
SLIDE 11

2020 Quality Measures

Measure Group Measure Status Data Goal Perinatal and Maternal Care Breast Feeding Existing Hospital Reported Process C-Section Existing Hospital Reported Outcome Pregnancy related depression Existing Hospital Reported Process Maternal Emergencies Existing Hospital Reported Process Family Planning Existing HCPF/Hospital Report Process Incidence of Episiotomy New HCFP Process Patient Safety Clostridium difficile (C-Diff) Existing HCPF/Hospital Report Outcome Adverse Event Existing Hospital Reported Process Culture of Safety Survey Existing Hospital Reported Process Sepsis New Hospital Reported Process Antibiotics Stewardship New Hospital Reported Process Handoffs and Signouts New Hospital Reported Process Patient Experience HCAHPS Existing HCPF Outcome Advanced Care Plan Existing Hospital Reported Process

11

slide-12
SLIDE 12

2020 Proposed Changes: Retired Measures

12

Three measure groups are being removed. These areas are going to be addressed in the Hospital Transformation Program. One measure (falls with injury) is being retired as the measure has topped out. A total of 9 measures are being retired. ❖ Behavioral Health

  • Follow-up appointments within 7 days after hospital discharge for a mental health condition
  • Follow-up appointments within 7 days after hospital discharge for a mental health condition
  • Emergency department utilization for mental health condition
  • Emergency department utilization for substance use condition

❖ Substance use

  • Using Alternatives to Opioids (ALTOs) in Hospital Emergency Departments
  • Post surgical Opioid Prescribing
  • Tobacco and Substance Use Screening and Intervention

❖ Addressing Cost of Care

  • Addressing cost of care

❖ Patient Safety

  • Falls with injury
slide-13
SLIDE 13

2020 Proposed Changes: New Measures

13

Four new measures are being proposed: ❖ Maternal Health and Perinatal Care

  • Incidence of episiotomy

❖ Patient Safety

  • Sepsis
  • Antibiotics Stewardship
  • Handoffs and Signouts
slide-14
SLIDE 14

Incidence of Episiotomy

Area: Maternal Health and Perinatal Care

NQF #0470 Incidence of Episiotomy - Percentage of vaginal deliveries (excluding those coded with shoulder dystocia) during which an episiotomy is performed. Numerator Statement:

  • Number of episiotomy procedures (ICD-9 code 72.1, 72.21, 72.31, 72.71, 73.6; ICD-10

PCS:0W8NXZZ performed on women undergoing a vaginal delivery (excluding those with shoulder dystocia ICD-10; O66.0) during the analytic period- monthly, quarterly, yearly etc. Denominator Statement:

  • All vaginal deliveries during the analytic period- monthly, quarterly, yearly etc. excluding those

coded with a shoulder dystocia ICD-10: O66.0). Exclusions:

  • Women who have a coded complication of shoulder dystocia. In the case of shoulder dystocia,

an episiotomy is performed to free the shoulder and prevent/mitigate birth injury to the infant.

14

slide-15
SLIDE 15

Sepsis

Area: Patient Safety

Sepsis Process Measure:

  • Describe the protocols and alerts your facility has in place for identifying sepsis and for

treating sepsis. If the protocols are different for different levels of care (e.g. ED vs inpatient), please describe the protocols and their differences.

  • Describe and provide evidence of the training that your facility has in place for orienting

new providers and staff to your facility’s systems and protocols for addressing suspected sepsis cases

  • Describe and provide evidence of the process of providing regular feedback to providers on

sepsis identification and treatment results.

  • Provide process measures and/or outcome measures your facility uses for tracking sepsis

identification and treatment as well as any results for the purposes of quality improvement

15

slide-16
SLIDE 16

Antibiotic Stewardships

Area: Patient Safety

16

This measure has four levels corresponding to a tiered point structure. The levels are cumulative, e.g a hospital must achieve Level I to potentially achieve Level II. This measure is based on the work that the Colorado Department of Public Health and Environment (CDPHE), the Colorado Hospital Association (CHA), Colorado Health Care Association (CHCA), and Telligen have done on antibiotic stewardship working towards developing an Antibiotic Stewardship Honor Roll. Level 1, Commitment: The hospital demonstrates leadership support for antibiotic stewardship and has an antibiotic stewardship committee that includes a physician and pharmacist that meets at least quarterly. Level 2, Education: The hospital meets criteria for Level 1, as well as the following:

  • Implements facility-specific treatment recommendations for common conditions, including community-acquired pneumonia,

urinary tract infection, and skin and soft-tissue infection,

  • Distributes an antibiogram annually or biannually, and
  • Provides education to clinicians and other relevant staff on improving antibiotic prescribing at least annually.

Level 3, Guidance: The hospital meets criteria for Level 1 and Level 2, as well as the following:

  • Implements one or more broad interventions to improve antibiotic use, such as antibiotic pre-authorization, prospective audit

with feedback, antibiotic time-outs, or pharmacy-driven interventions designed for the antibiotic stewardship program, such as automatic alerts for, and de-escalation of, unnecessarily duplicative therapy, or time-sensitive automatic stop orders,

  • Tracks antibiotic use (days of therapy or defined daily doses), and
  • Reports antibiotic use to prescribers at least once every 6 months.

Level 4, Collaboration: The hospital meets criteria for Level 1, Level 2, and Level 3 as well as the following during the measurement period:

  • Collaborates with one or more facilities, such as other hospitals or long-term care facilities, to implement coordinated antibiotic

stewardship, and

  • Reports antibiotic use to the National Healthcare Safety Network (3 or more months).
slide-17
SLIDE 17

Antibiotic Stewardships Continued

Area: Patient Safety

17

Each level is cumulative, a hospital has to meet the conditions and provide documentation and supporting evidence for the highest level it wishes to obtain as well as those below it. (e.g. to achieve level 3 hospitals must meet the criteria and submit documentation that meets levels 1 – 3). Measure details: Level 1 ❖ Hospitals must answer yes to the following questions and provide supporting documentation:

  • Does your hospital have formal, written support from leadership (e.g., a policy statement) that supports

efforts to improve antibiotic use (antibiotic stewardship)?

  • Is there a physician leader responsible for program outcomes of stewardship activities at your hospital?
  • Is there a pharmacist leader responsible for working to improve antibiotic use at your hospital?
  • Is there an antibiotic stewardship committee that meets at least quarterly?

❖ Documentation: Document dates of antibiotic stewardship committee meetings and include the names and position descriptions of attendees (e.g., “physician leader”). ❖ Letter of support: The letter must indicate support for improving antibiotic stewardship and attest that there is an antibiotic stewardship committee that includes physician and pharmacist leaders and meets at least quarterly.

slide-18
SLIDE 18

Antibiotic Stewardships Continued

Area: Patient Safety

Measure details: Level 2 ❖ Does your hospital have facility-specific treatment recommendations, based on national guidelines and local susceptibility, to assist with antibiotic selection for the following common conditions (must answer yes to all)?

  • Community-acquired pneumonia
  • Urinary tract infection
  • Skin and soft-tissue infection

❖ Does your hospital produce an antibiogram (cumulative antibiotic susceptibility report) and distribute the antibiogram to prescribers annually or every other year? ❖ Does your stewardship program provide education to clinicians and other relevant staff on improving antibiotic prescribing at least annually? ❖ Documentation:

  • Upload evidence of facility-specific treatment guidelines based on national guidelines for community-

acquired pneumonia, urinary tract infection, and skin and soft-tissue infection

  • Indicate general references to the national guidelines upon which facility-specific guidelines are based

(e.g., Infectious Diseases Society of America).

  • Dates and topics of education to clinicians and staff, must include at least 1 training during the

measurement period.

  • Provide the date of the hospital’s latest antibiogram
  • Letter of support including the information outlined in Level I as well as an attestation to the availability
  • f facility-specific treatment guidelines based on national guidelines and attest to the education of

clinicians and staff on antibiotic stewardship at least annually.

18

slide-19
SLIDE 19

Antibiotic Stewardships Continued

Area: Patient Safety

Measure details: Level 3 ❖ Does your hospital conduct any of the following broad interventions to improve antibiotic use? (yes to one or more)

  • Do specified antibiotic agents need to be approved by a designated physician or pharmacist

prior to dispensing (i.e., pre-authorization) at your hospital?

  • Does a designated physician or pharmacist routinely review courses of therapy for specified

antibiotic agents and provide verbal or written feedback to prescribers with 72 hours after the initial orders (i.e., prospective audit with feedback) at your hospital?

  • Is there a formal antibiotic time-out procedure during which clinicians review the

appropriateness of antibiotics within 72 hours after the initial orders?

  • Pharmacy-driven interventions for antibiotic stewardship including at least one of the

following:

  • Automatic alerts and de-escalation of therapy in situations where therapy might be

unnecessarily duplicative

  • Or time-sensitive automatic stop orders for specified antibiotic prescriptions?

19

slide-20
SLIDE 20

Antibiotic Stewardships Continued

Area: Patient Safety

Measure details: Level 3 Continued ❖ Does your hospital monitor antibiotic use (consumption) at the unit and/or hospital-wide level by one of the following metrics? (yes to one or more)

  • By counts of antibiotic(s) administered to patients per day (Days of Therapy; DOT). DOT is defined as an

aggregate sum of days for which any amount of a specified antimicrobial agent is administered or dispensed to a particular patient (numerator) divided by a standardized denominator (e.g., patient-days, days present, or admissions).

  • By number of grams of antibiotics used (Defined Daily Dose, DDD)? (DDD is defined as the aggregate

number of grams of each antibiotic purchased, dispensed, or administered during a period of interest divided by the World Health Organization-assigned DDD and divided by a standard denominator (e.g., patient-days, days present, or admissions). ❖ Does your hospital report information to staff on improving antibiotic use and resistance? (yes to one or more)

  • Does your stewardship program share facility-specific reports on antibiotic use with prescribers at least
  • nce every 6 months?
  • Do prescribers receive direct, personalized communication about how they can improve their antibiotic

prescribing at least once every 6 months?

20

slide-21
SLIDE 21

Antibiotic Stewardships Continued

Area: Patient Safety

Measure details: Level 3 Continued ❖ Documentation:

  • Provide a description of the process for the above intervention(s) (pre-authorization, prospective audit

with feedback, antibiotic time-out, or pharmacy-driven intervention), including:

  • What antimicrobial agents are targeted by the intervention,
  • Who implements the intervention,
  • How the intervention is implemented, AND
  • When the intervention is implemented (during the course of patient care)
  • Provide a description of
  • how DOT or DDD are measured, and
  • what antibiotic utilization information is reported to prescribers and how. Include examples
  • f antibiotic utilization reports.
  • Letter of support including the information outlined in Levels I and 2 as well as:
  • The letter must attest to facility practice of one or more of the above broad interventions to

improve antibiotic use (antibiotic pre-authorization, prospective audit with feedback, antibiotic time-out, or pharmacy interventions), the tracking of antibiotic days of therapy or defined daily doses, and the report of antibiotic use data to prescribers at least once every six months.

21

slide-22
SLIDE 22

Antibiotic Stewardships Continued

Area: Patient Safety

Measure details: Level 4 In order to achieve this level, the hospital must complete both activities. ❖ Has your hospital collaborated with one or more facilities, such as other hospitals or long-term care facilities, to implement coordinated antibiotic stewardship?

  • Examples include shared infectious diseases physician or pharmacy oversight of antibiotic

stewardship activities among multiple facilities, implementation of broad interventions to improve antibiotic use as defined for Level 3, Guidance, to multiple facilities, multi-facility efforts to track and report antibiotic use, or participation in a state or national public health collaborative. ❖ Does your hospital regularly report antibiotic use data to NHSN via the Antibiotic Use and Resistance Module (3 or more months during the measurement period)? ❖ Documentation:

  • Description and evidence of the dates of collaboration, the name and facility type of collaborating

facilities, and a description of the coordinated intervention.

  • Provide the dates of reporting antibiotic use data to NHSN, as well as evidence of the reporting.
  • Letter of support to include all of the information in Levels 1-3 and letter must attest to hospital

participation in collaborative antibiotic stewardship efforts with other healthcare facilities and report of ≥3 months of antibiotic use data to NHSN.

22

slide-23
SLIDE 23

Handoffs and Signouts

Area: Patient Safety

23

Hospitals had identified this area in their patient safety surveys as an area that needed

  • improvement. The subcommittee noted that different hospitals may use different tools, and

different hospitals may have different areas where they need to improve handoffs and signouts. Based on this feedback this process measure was developed. Three-step Process Measure: Step 1: Hospitals must identify the areas of handoffs and signouts that they need to improve on and focus on the area that has the most need. Hospitals should look at both areas that have the greatest need for improvement and areas with the highest severity of potential harm. This can be accomplished by reviewing the results of their patient safety survey or other means. These handoffs and signouts can be between different levels of care, between departments, or other areas where providers transition care between themselves or other hospital staff. Step 2: Hospitals must describe the process they are using to address handoffs and transitions Step 3: Hospitals must describe how they will measure the implementation and performance of the programs and complete the following tasks:

slide-24
SLIDE 24

Handoffs and Signouts Continued

Area: Patient Safety

24

Three-step Process Measure: Step 1: Hospitals must identify the areas of handoffs and signouts that they need to improve on and focus on the area that has the most need. Hospitals should look at both areas that have the greatest need for improvement and areas with the highest severity of potential harm. This can be accomplished by reviewing the results of their patient safety survey or other means. These handoffs and signouts can be between different levels of care, between departments, or other areas where providers transition care between themselves or other hospital staff.

  • Hospitals must provide a narrative description of the area they are addressing. They should provide evidence that quality

needs to be improved in this area. Examples of transitions include:

  • Operating room to intensive care unit
  • Emergency department to inpatient
  • Intensive care unit to floor
  • Perioperative services to next level of care
  • Intraoperative: provider to provider
  • Postoperative: OR to Post Anesthesia Care Unit (PACU)

Step 2: Hospitals must describe the process they are using to address handoffs and transitions

  • Identify the leader of the initiative
  • Describe the actions being taken to improve handoffs and signouts
  • Document any standardized methodologies or mnemonics being implemented (e.g IPASS, SBAR, etc)
  • Document any training that has been done in the past year to address this issue or training plans to be conducted.
slide-25
SLIDE 25

Handoffs and Signouts Continued

Area: Patient Safety

Process Measure: Step 3: Hospitals must describe how they will measure the implementation and performance of the programs and complete the following tasks:

  • Describe how it plans to measure progress on this initiative in HQIP 2021
  • Potential measurement strategies include:
  • Tracking how many times a handoff or signout uses the appropriate protocol
  • Reviewing incident reports and documenting the times there are handoff issues pre

intervention vs post intervention

  • Handoff direct observation (pre-intervention and post-intervention)
  • Record presence or absence of key elements
  • Analyze quality (presence of distractions, attentiveness of speaker and recipient,

asking important clinical questions etc.)

  • Surveys to providers and staff about their perceptions of handoff process/perceived

barriers to improvements in the handoff process

  • Hospitals must document the process of communicating feedback on handoffs and signouts to

hospital staff to facilitate continuous improvement.

25

slide-26
SLIDE 26

Handoffs and Signouts Continued

Area: Patient Safety

Step 3 Examples Based on Care Settings: ❖ Operating Room (OR) to Intensive Care Unit (ICU):

  • Review handoffs using the following:
  • Handoff assessment tool (checklist of items essential to reports from the transmitting OR team to the

receiving ICU team)

  • Past medical history, reason for ICU admission, allergies, airway, breathing/ventilation,

circulation/hemodynamics, inputs, outputs, drains/lines, complications, plan, team contact information, and family information

  • Score the quality of hand off delivery (concise, clear, and organized hand-offs receive higher scores)
  • Score the recipient based on eye contact, affirmatory statements, head nodding, note taking, and

question asking. ❖ Transfer to ICU:

  • Analyze critical messages (CM) for the following information:
  • Time till Rapid Response Team (RRT) activation
  • Message quality
  • Presence of vitals
  • Quality/timeliness of physician response

26

slide-27
SLIDE 27

Thank You

Matt Haynes Special Finance Projects Manager Department of Health Care Policy & Financing Matt.haynes@state.co.us